Block Commodities Ltd (BLCC)
Block Commodities Ltd: Appointment of Chief Medical Officer to Scientific
Advisory Board (SAB)
03-Jun-2019 / 11:40 GMT/BST
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
The information communicated within this announcement is deemed to
constitute inside information as stipulated under the Market Abuse
Regulations (EU) No. 596/2014. Upon the publication of this announcement,
this inside information is now considered to be in the public domain.
Block Commodities Limited
("Block Commodities" or the "Company")
Block Commodities Limited / Epic: BLCC / Sector: Mining
Appointment of Chief Medical Officer to Scientific Advisory Board (SAB)
Block Commodities, the innovative commodity trader operating in Africa, is
pleased to announce the appointment of Dr. Frank D'Ambrosio as Chief Medical
Officer to the Company's Scientific Advisory Board (SAB) to oversee the
Company's operations within the medicinal cannabis market.
Dr. D'Ambrosio is one of the world's leading campaigners for policy reform
on the use of medical cannabis. A surgeon with over 30 years' experience, he
has studied the effects of cannabis-based medicine for different purposes
such as chronic pain and post-traumatic stress disorder. For the last six
years, he has dedicated his medical practice to helping patients in the US
incorporate medical cannabis into the everyday care. Moreover, he hopes to
educate individuals and authorities on the benefits of medicinal cannabis,
through his insights as a doctor, advocate and entrepreneur.
In November of last year, Dr. D'Ambrosio spoke at the World Health
Organisation's ("WHO") 41st Expert Committee on Drug Dependence about the
benefits of medical cannabis. A few days later he addressed British MPs,
pressing for reform to the current UK regulations relating to medicinal
cannabis.
Dr. Frank D'Ambrosio commented:
"I am very glad to join Block Commodities as they are one of the first
companies to enter the European medicinal cannabis market.
"We are leaving behind myths and misconceptions, which largely benefits
patients who could only rely on big pharma to treat their conditions. This
represents an opportunity not only for investors, but also to build a more
comprehensive range of healthcare options in order to help patients to
achieve a better quality of life."
Chris Cleverly, Executive Chairman of Block Commodities commented:
"Dr. D'Ambrosio's extensive experience and specialisation will prove
invaluable to our Company as we develop a full strategy to deploy medicinal
cannabis as a therapy."
About Block Commodities
Block Commodities is a commodity-focused trading company aiming to maximise
value in African agriculture through the deployment of blockchain
technologies. The Company works closely with African farmers to help raise
agricultural productivity and to secure better returns for their produce.
New technologies such as blockchain enhance transparency, accountability and
efficiency in a market with enormous potential.
The Company has implemented Farmer 3.0, a blockchain-powered ecosystem that
connects all market participants to facilitate commercial transactions.
Building on well-established connections and technology expertise, the
Company has expanded its operations into the medicinal cannabis market with
a strategy to produce and process cannabis-based products via licences in
Africa, to supply the growing demand in Europe.
For more information, visit: http://www.blockcommodities.com [1]
The Directors of the Company accept responsibility for the content of this
announcement.
For further information, please contact:
Block Commodities Limited
Chris Cleverly info@blockcommodities.com
NEX Exchange Corporate Adviser:
Alexander David Securities Limited
David Scott - Corporate Finance +44 (0) 20 7448 9820
James Dewhurst - Corporate Broking +44 (0) 20 7448 9820
Public and Investor Relations:
Cassiopeia Services - Stefania stefania@cassiopeia-ltd.com
Barbaglio
ISIN: GG00B4QYTJ50
Category Code: BOA
TIDM: BLCC
LEI Code: 2138001KNTXRAZTFKU51
Sequence No.: 8933
EQS News ID: 818441
End of Announcement EQS News Service
1: https://link.cockpit.eqs.com/cgi-bin/fncls.ssp?fn=redirect&url=03b29e1310876849804d55b530223477&application_id=818441&site_id=vwd_london&application_name=news
(END) Dow Jones Newswires
June 03, 2019 06:42 ET (10:42 GMT)
